Results from a Phase 2 clinical trial shows that stem cell transplants can provide better long-term benefits than the standard…
Alice Melão, MSc
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Alice Melão, MSc
Scleroderma patients with lung diseases have shorter lifespans than those without pulmonary conditions, underscoring the need for better treatments for…
Corbus Pharmaceuticals has extended its intellectual property portfolio with a new patent for its investigative cannabinoid-derived drug candidate…
Non-invasive Shock Wave Therapy Speeds Healing of Digital Ulcers in Systemic Sclerosis, Study Shows
Non-invasive extracorporeal shock wave therapy (ESWT) was shown to significantly improve the wound healing process in patients with systemic sclerosis…
Corbus Pharmaceuticals has extended its intellectual property portfolio with a new patent fo its investigative cannabinoid-derived drug candidate…
New mutations found in the GNPTG gene were identified as the underlying cause of a familial form of a scleroderma-like disease,…
A new treatment using adipose-derived regenerative cells (ADRCs) to treat hand problems caused by scleroderma is now available at…
Urinary symptoms are frequent in patients with systemic sclerosis (SSc), especially in patients with limited cutaneous SSc, which have…
The World Scleroderma Foundation (WSF) will host the 5th Systemic Sclerosis World Congress from Feb. 15-17, 2018, in Bordeaux, France.
Results from a multicenter clinical trial in Belgium further demonstrated the therapeutic effects of rituximab, marketed by Genentech…